Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Praxis Precision Medicines, Inc.PRAX · Entity 3538 | General Counsel and Secretary | May 14, 2026 | May 20, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Praxis Precision Medicines, Inc.
Report date May 14, 2026 · Filed May 20, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 26,010.667 |
Reported balance
After 2026-05-14 transaction · row 1
1 source rowRow 1 · 2026-05-14 · Grant · Acquired 78 · Balance 26,010.667 F1: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 14, 2026 Filed May 20, 2026 01:45 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 78 | $167.94 | $13,099.55 |
DisclosureSEC source: 0001827760-26-000007 · wk-form4_1779241516.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,010.667 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 01:19 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 768 | $275.74 | $211,768.32 |
DisclosureSEC source: 0001827760-26-000005 · wk-form4_1768353556.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,932.667 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| January 10, 2026 Filed Jan 12, 2026 22:49 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 917 | $288.45 | $264,508.65 |
DisclosureSEC source: 0001689548-26-000012 · wk-form4_1768258193.xml · nonDerivative · entry 2 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,700.667 F2 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 22:49 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 5,500 | $0.00 Strike: $294.38 | $0.00 |
DisclosureSEC source: 0001689548-26-000012 · wk-form4_1768258193.xml · derivative · entry 3 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,500 Underlying: Common Stock · 5,500 shares Expires 2036-01-08 F3 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 8, 2027 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 08, 2026 Filed Jan 12, 2026 22:49 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 6,875 | $0.00 | $0.00 |
DisclosureSEC source: 0001689548-26-000012 · wk-form4_1768258193.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,617.667 F1 · kind: Mr. Nemiroff was awarded 6,875 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 8, 2026. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| January 07, 2026 Filed Jan 9, 2026 21:47 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 89 | $292.63 | $26,044.07 |
DisclosureSEC source: 0001827760-26-000002 · wk-form4_1767995242.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,742.667 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:41 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionStock Option (Right to Buy) · Derivative | 9,100 | $0.00 Strike: $56.94 | $0.00 |
DisclosureSEC source: 0001104659-25-115099 · tm2531977-2_4seq1.xml · derivative · entry 14 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,717 Underlying: Common Stock · 9,100 shares Expires 2034-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:41 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,652 | $0.00 Strike: $44.40 | $0.00 |
DisclosureSEC source: 0001104659-25-115099 · tm2531977-2_4seq1.xml · derivative · entry 13 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,347 Underlying: Common Stock · 5,652 shares Expires 2033-01-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares underlying this stock option vested as to 25% on January 12, 2024 and the remaining shares vest in substantially equal monthly installments over the following 36 months, subject to the Reporting Person's continued service through each vesting date. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:41 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionStock Option (Right to Buy) · Derivative | 2,434 | $0.00 Strike: $44.40 | $0.00 |
DisclosureSEC source: 0001104659-25-115099 · tm2531977-2_4seq1.xml · derivative · entry 12 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,434 shares Expires 2033-01-12 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:41 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionStock Option (Right to Buy) · Derivative | 6,230 | $0.00 Strike: $133.65 | $0.00 |
DisclosureSEC source: 0001104659-25-115099 · tm2531977-2_4seq1.xml · derivative · entry 11 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,230 shares Expires 2030-09-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: This option was fully vested as of September 9, 2024. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:41 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,714 | $0.00 Strike: $83.85 | $0.00 |
DisclosureSEC source: 0001104659-25-115099 · tm2531977-2_4seq1.xml · derivative · entry 10 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,714 shares Expires 2030-06-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: This option was fully vested as of January 1, 2024. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:41 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | SaleCommon Stock | 9,100 | $194.30 | $1,768,130.00 |
DisclosureSEC source: 0001104659-25-115099 · tm2531977-2_4seq1.xml · nonDerivative · entry 9 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,831.667 Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:41 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | SaleCommon Stock | 977 | $193.23 | $188,788.64 |
DisclosureSEC source: 0001104659-25-115099 · tm2531977-2_4seq1.xml · nonDerivative · entry 8 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,931.667 F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $193.010 to $193.960. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:41 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | SaleCommon Stock | 13,339 | $192.53 | $2,568,197.69 |
DisclosureSEC source: 0001104659-25-115099 · tm2531977-2_4seq1.xml · nonDerivative · entry 7 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,908.667 F2 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $192.003 to $193.000. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:41 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | SaleCommon Stock | 1,714 | $190.86 | $327,139.18 |
DisclosureSEC source: 0001104659-25-115099 · tm2531977-2_4seq1.xml · nonDerivative · entry 6 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,247.667 F1 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $190.720 to $191.540. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:41 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionCommon Stock | 9,100 | $56.94 | $518,154.00 |
DisclosureSEC source: 0001104659-25-115099 · tm2531977-2_4seq1.xml · nonDerivative · entry 5 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,961.667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:41 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionCommon Stock | 5,652 | $44.40 | $250,948.80 |
DisclosureSEC source: 0001104659-25-115099 · tm2531977-2_4seq1.xml · nonDerivative · entry 4 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,861.667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:41 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionCommon Stock | 2,434 | $44.40 | $108,069.60 |
DisclosureSEC source: 0001104659-25-115099 · tm2531977-2_4seq1.xml · nonDerivative · entry 3 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,209.667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:41 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionCommon Stock | 6,230 | $133.65 | $832,639.50 |
DisclosureSEC source: 0001104659-25-115099 · tm2531977-2_4seq1.xml · nonDerivative · entry 2 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,775.667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 20, 2025 Filed Nov 22, 2025 02:41 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionCommon Stock | 1,714 | $83.85 | $143,718.90 |
DisclosureSEC source: 0001104659-25-115099 · tm2531977-2_4seq1.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,545.667 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2025 Filed Feb 14, 2025 21:29 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 51 | $85.40 | $4,355.40 |
DisclosureSEC source: 0001689548-25-000027 · wk-form4_1739568581.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,831.667 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| January 12, 2025 Filed Jan 14, 2025 23:50 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 579 | $63.15 | $36,563.85 |
DisclosureSEC source: 0001689548-25-000013 · wk-form4_1736898626.xml · nonDerivative · entry 2 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,882.667 F2 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported restricted stock units. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 23:50 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 22,500 | $0.00 Strike: $63.15 | $0.00 |
DisclosureSEC source: 0001689548-25-000013 · wk-form4_1736898626.xml · derivative · entry 3 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,500 Underlying: Common Stock · 22,500 shares Expires 2035-01-10 F3 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 10, 2026 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 10, 2025 Filed Jan 14, 2025 23:50 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 11,250 | $0.00 | $0.00 |
DisclosureSEC source: 0001689548-25-000013 · wk-form4_1736898626.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,461.667 F1 · shares: Mr. Nemiroff was awarded 11,250 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of January 10, 2025. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| January 07, 2025 Filed Jan 9, 2025 00:50 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 89 | $77.52 | $6,899.28 |
DisclosureSEC source: 0001689548-25-000006 · wk-form4_1736383807.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,211.667 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| November 14, 2024 Filed Nov 16, 2024 02:30 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionStock Option (Right to Buy) · Derivative | 7,583 | $0.00 Strike: $56.94 | $0.00 |
DisclosureSEC source: 0001104659-24-119844 · tm2428636-2_4seq1.xml · derivative · entry 3 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,817 Underlying: Common Stock · 7,583 shares Expires 2034-07-29 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the reporting person's continued service through each vesting date. Read SEC document |
| November 14, 2024 Filed Nov 16, 2024 02:30 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | SaleCommon Stock | 8,239.333 | $80.20 | $660,827.46 |
DisclosureSEC source: 0001104659-24-119844 · tm2428636-2_4seq1.xml · nonDerivative · entry 2 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,300.667 F1 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $80.12 to $80.21. The Reporting Person undertakes to provide upon request from the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 14, 2024 Filed Nov 16, 2024 02:30 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Exercise / conversionCommon Stock | 7,583 | $56.94 | $431,776.02 |
DisclosureSEC source: 0001104659-24-119844 · tm2428636-2_4seq1.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,540 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 01:02 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 36,400 | $0.00 Strike: $56.94 | $0.00 |
DisclosureSEC source: 0001104659-24-084505 · tm2420554-3_4seq1.xml · derivative · entry 2 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,400 Underlying: Common Stock · 36,400 shares Expires 2034-07-29 F2 · derivative.exercise_date: The shares underlying this stock option vested as to 7/48ths on July 29, 2024 and the remaining shares vest in substantially equal monthly installments over the following 41 months, subject to the reporting person's continued service through each vesting date. Read SEC document |
| July 29, 2024 Filed Aug 1, 2024 01:02 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 7,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-084505 · tm2420554-3_4seq1.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,957 F1 · shares: Mr. Nemiroff was awarded 7,800 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 12, 2025, subject to the reporting person's continued service through each vesting date. The restricted stock units have no expiration date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:12 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 51 | $44.65 | $2,277.15 |
DisclosureSEC source: 0001689548-24-000026 · wk-form4_1707945111.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,157 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| January 12, 2024 Filed Jan 17, 2024 21:48 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $43.37 | $0.00 |
DisclosureSEC source: 0001689548-24-000019 · wk-form4_1705528127.xml · derivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-01-12 F1 · derivative.exercise_date: The shares underlying this stock option vest as follows: 50% vested in full on January 12, 2024 (the "Grant Date") and the remaining 50% vesting over a four-year period, with 25% of such shares vesting on the first anniversary of the Grant Date and the remaining shares vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 07, 2024 Filed Jan 10, 2024 02:10 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 89 | $25.19 | $2,241.91 |
DisclosureSEC source: 0001689548-24-000007 · wk-form4_1704852610.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,208 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| May 12, 2023 Filed May 19, 2023 01:47 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 11,686 | $0.88 | $10,330.42 |
DisclosureSEC source: 0001689548-23-000091 · wf-form4_168446085671144.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,460 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 12, 2023 Filed Feb 14, 2023 01:45 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 920 | $3.94 | $3,624.80 |
DisclosureSEC source: 0001689548-23-000049 · wf-form4_167633907475346.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,774 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| January 12, 2023 Filed Jan 13, 2023 12:41 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 36,520 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001689548-23-000014 · wf-form4_167361370297959.xml · derivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,520 Underlying: Common Stock · 36,520 shares Expires 2033-01-12 F1 · shares: Mr. Nemiroff opted to receive this option grant in lieu of a cash bonus for the fiscal year ended December 31, 2022. Read SEC document |
| January 12, 2023 Filed Jan 18, 2023 00:32 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 120,000 | $0.00 Strike: $2.96 | $0.00 |
DisclosureSEC source: 0001689548-23-000025 · wf-form4_167400190581060.xml · derivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2033-01-12 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 12, 2024 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 07, 2023 Filed Jan 9, 2023 23:18 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 1,335 | $2.52 | $3,364.20 |
DisclosureSEC source: 0001689548-23-000007 · wf-form4_167330631711128.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,694 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| November 14, 2022 Filed Nov 21, 2022 11:03 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 682 | $1.81 | $1,235.10 |
DisclosureSEC source: 0001689548-22-000127 · wf-form4_166902858348469.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,029 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 20:48 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $2.12 | $0.00 |
DisclosureSEC source: 0001689548-22-000092 · wf-form4_165610371798079.xml · derivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2032-06-22 F1 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on June 22, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| June 13, 2022 Filed Jun 14, 2022 23:56 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | PurchaseCommon Stock | 7,500 | $1.63 | $12,225.00 |
DisclosureSEC source: 0001689548-22-000080 · wf-form4_165525096436926.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,347 Read SEC document |
| May 13, 2022 Filed May 18, 2022 21:49 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 2,202 | $8.80 | $19,373.20 |
DisclosureSEC source: 0001689548-22-000048 · wf-form4_165291056557529.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,847 F1 · kind: These shares were acquired under the Praxis Precision Medicines, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). Read SEC document |
| February 12, 2022 Filed Feb 16, 2022 00:36 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | Tax withholdingCommon Stock | 755 | $12.85 | $9,701.75 |
DisclosureSEC source: 0001689548-22-000006 · wf-form4_164497179947982.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,645 F1 · kind: Shares withheld by the Issuer to satisfy the tax withholding obligations in connection with the vesting of certain previously reported Restricted Share Units. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:08 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 63,000 | $0.00 Strike: $18.11 | $0.00 |
DisclosureSEC source: 0001104659-22-003160 · tm222494-3_4seq1.xml · derivative · entry 2 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,000 Underlying: Common Stock · 63,000 shares Expires 2032-01-07 F2 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on January 7, 2023 and the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the reporting person's continued service through each vesting date. Read SEC document |
| January 07, 2022 Filed Jan 11, 2022 21:08 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 18,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-003160 · tm222494-3_4seq1.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,400 F1 · shares: Mr. Nemiroff was awarded 18,000 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on January 7, 2023, subject to the reporting person's continued service through each vesting date. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 21:57 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantStock Option (Right to Buy) · Derivative | 43,400 | $0.00 Strike: $52.53 | $0.00 |
DisclosureSEC source: 0001689548-21-000012 · wf-form4_161359901747711.xml · derivative · entry 2 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,400 Underlying: Common Stock · 43,400 shares Expires 2031-02-12 F2 · derivative.exercise_date: The shares underlying this stock option vest over a four-year period, with 25% vesting on the one-year anniversary of the vesting commencement date of February 12, 2021 and the remaining 75% vesting in 36 equal monthly installments following such first anniversary, subject to the reporting person's continued service through each vesting date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 21:57 UTC | Praxis Precision Medicines, Inc. PRAX · Entity 3538 | GrantCommon Stock | 12,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001689548-21-000012 · wf-form4_161359901747711.xml · nonDerivative · entry 1 Nemiroff Alex · CIK 0001827760 · General Counsel and Secretary 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,400 F1 · shares: Mr. Nemiroff was awarded 12,400 restricted stock units. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. The restricted stock units vest in equal annual installments over a four-year period beginning on the one-year anniversary of the vesting commencement date of February 12, 2021. The restricted stock units may be settled only by delivering shares of the Issuer's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.